DPP4 and Hypoglycemia: A thiazolidinedione or a dipeptidyl peptidase-4 (DPP-4) inhibitor may be considered as second-line options in place of a sulphonylurea if there is a significant risk of hypoglycaemia, or if a sulphonylurea is contraindicated or not tolerated.